Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness.
Drinking away fatigue in multiple sclerosis.
Neuromyelitis optica and tactile and visual hallucinations in an elderly patient.
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.
Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
Olfactory dysfunction as a marker of multiple sclerosis progression.
Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.
Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
List of Abbreviations.
Radiologically isolated syndrome: An update on a rare entity.
Weighing Evidence from Mendelian Randomization-Early-Life Obesity as a Causal Factor in Multiple Sclerosis?
[Cell depletion and myoablation for neuroimmunological diseases].
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
The Myelinogenesis Process in Undernourished Rats Rehabilitated with Different Dietary Lipids.
[Effect of axonal developmental disorders in the corpus callosum on the neurological function after birth in septic neonatal rats].
Fampridine and quality of life in individuals with multiple sclerosis.
Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing.
Recovery from Toxic-Induced Demyelination Does Not Require the NG2 Proteoglycan.
Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.
Diffusion tensor imaging with direct cytopathological validation: characterisation of decorin treatment in experimental juvenile communicating hydrocephalus.
Three cases of neuromyelitis optica spectrum disorder.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Pages
« first
‹ previous
…
809
810
811
812
813
814
815
816
817
…
next ›
last »